Former Amazon Cares leader raises $3.5M for a startup serving caregivers for dementia and Alzheimer's patients.

This alarming statistic was discussed during a seminar titled “Dementia Care and Conservation of Universal Human Rights”, held today (25 November) at the National Skills Development Authority (NSDA) ...

The hospital-at-home movement has proliferated during the last decade, reshaping how acute care is delivered and health ...

Some patients frequently call 911. A new Bloomington fire unit tries to address the underlying causes to improve the patients ...

Simufilam did not show a significant reduction in cognitive or functional decline versus placebo in patients with ...

IGC Pharma, Inc. ("IGC Pharma" or the "Company") today announced additional interim data from its ongoing Phase 2 clinical trial evaluating IGC-AD1. The trial focuses on agitation in Alzheimer's as ...

Ah, constipation – the discomfort we've all faced at some point in our lives. If you've ever wondered about the ins and outs ...

Simufilam did not show a significant reduction in cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer's disease in the ReThink-ALZ Phase 3 study Simufilam contin ...

Great Place To Work, a research and consultancy agency,  recently announced the 22nd edition of its annual list of the 40 ...

“The man,” as she called him, did not exist; like many people with dementia, my mom suffered from hallucinations and delusions. We kept Mom in her apartment as long as possible, as she would have ...

(JAMA Neurology) Mailed educational interventions directed at patients, caregivers, and clinicians didn't reduce inappropriate prescribing of certain high-risk medications for people with Alzheimer's ...

Caregiver responsibilities take people away from work and social engagements, and respite is almost nonexistent. I’ve seen ...